Table 4 Prevalence of mucocutaneous disorders among HIV infected children by WHO and CDC disease progression (n = 347)
WHO paediatric stage | ||||
|---|---|---|---|---|
Mucocutaneous disorders: Present n = 294 (%) | Mucocutaneous disorders: Absent n = 53 (%) | Total n = 347 (%) | p-value | |
I | 2 (29) | 5 (71) | 7 (2) | |
II | 116 (76) | 37 (24) | 153 (44) | <0.01 |
III | 166 (94) | 11 (6) | 177 (51) | |
IV | 10 (100) | 0 (0) | 10 (3) | |
Immunosuppression level by CDC | ||||
No evidence | 74 (71) | 30 (29) | 104 (30) | |
Moderate | 109 (84.5) | 20 (15.5) | 129 (37) | <0.01 |
Severe | 111 (97) | 3 (3) | 114 (33) |